Clinical trial
Combination Chemotherapy in Treating Children With Newly Diagnosed Malignant…
NCT00066482 · Children's Oncology Group, Other · Completed
Key facts
| NCT number | NCT00066482 |
|---|---|
| Title | Combination Chemotherapy in Treating Children With Newly Diagnosed Malignant Germ Cell Tumors |
| Official title | Pilot Study of Cisplatin, Etoposide, Bleomycin and Escalating Dose Cyclophosphamide Therapy for Children With High Risk Malignant Germ Cell Tumors |
| Lead sponsor | Children's Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor |
| Intervention type | Biological, Drug, Procedure |
| Interventions | bleomycin sulfate, filgrastim, cisplatin, cyclophosphamide, etoposide, conventional surgery, MESNA |
| Enrollment | 19 |
| Start date | Jul 1, 2004 |
| Primary completion | Apr 1, 2007 |
| First posted | Aug 7, 2003 |
| Last update posted | Oct 17, 2013 |
| Countries | Australia, Canada, Puerto Rico, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: